THE SIGNAL
BY
THE ARCH

Where Web3 founders, talent, and partners meet.

Directory

  • Partners Directory
  • All Categories
  • Compare Partners
  • For Founders
  • Find Your Match
  • Pricing

Get Involved

  • Get Listed
  • Submit an Event
  • Become an Operative
  • Refer a Client
  • Get Your Badge
  • 📅 Book a Call

News & Intelligence

  • Web3 News
  • Daily Digests
  • Intelligence Reports
  • Web3 Events
  • RSS Feed
  • Substack Newsletter

Company

  • About
  • How It Works
  • Manifesto
  • Demo

Legal

  • Privacy
  • Terms
  • Cookies

Resources

  • Guides
  • Sales Decks
  • Docs

© 2026 THE SIGNAL. All rights reserved.

THE SIGNAL
BY
THE ARCH

Where Web3 founders, talent, and partners meet.

Directory

  • Partners Directory
  • All Categories
  • Compare Partners
  • For Founders
  • Find Your Match
  • Pricing

Get Involved

  • Get Listed
  • Submit an Event
  • Become an Operative
  • Refer a Client
  • Get Your Badge
  • 📅 Book a Call

News & Intelligence

  • Web3 News
  • Daily Digests
  • Intelligence Reports
  • Web3 Events
  • RSS Feed
  • Substack Newsletter

Company

  • About
  • How It Works
  • Manifesto
  • Demo

Legal

  • Privacy
  • Terms
  • Cookies

Resources

  • Guides
  • Sales Decks
  • Docs

© 2026 THE SIGNAL. All rights reserved.

The Signal Logo
THE SIGNAL
PARTNERSINSIGHTSEVENTS
GET LISTED
News
Novo Nordisk's Wegovy Pill Launches, Expanding Acc...
Decrypt •Monday, January 5, 2026 at 08:43 PM•1 min read

Novo Nordisk's Wegovy Pill Launches, Expanding Access to Weight-Loss Drugs

Share:
The Signal TakeNeutral
AltcoinsRegulation

Novo Nordisk has launched a once-daily Wegovy pill, marking the first oral GLP-1 medication approved for weight loss in the U.S. According to reports, this development provides an alternative to injectable treatments, which have seen significant demand. The Wegovy pill aims to broaden access to GLP-1 weight-loss drugs, offering a new option for individuals seeking treatment.

Read full story at Decrypt
Share:
📱

Never miss a Web3 update

Join our Telegram channel to receive news in real-time, straight to your phone.

Join Channel

Related News

Inside the Growing ‘Digisexual’ Subculture of People in Relationships With AI

Decrypt •1h ago

Kalshi, Polymarket eye $20B valuations in potential fundraising: WSJ

Cointelegraph•2h ago

USDC Surpasses Tether as Stablecoin Volume Reaches Record $1.8 Trillion

Cointelegraph•4h ago

Why Bitcoin keeps snapping back to $70k — and the $13B options “magnet” behind it

CryptoSlate•4h ago
← Back to News Feed
The Signal Logo
THE SIGNAL
PARTNERSINSIGHTSEVENTS
GET LISTED
News
Novo Nordisk's Wegovy Pill Launches, Expanding Acc...
Decrypt •Monday, January 5, 2026 at 08:43 PM•1 min read

Novo Nordisk's Wegovy Pill Launches, Expanding Access to Weight-Loss Drugs

Share:
The Signal TakeNeutral
AltcoinsRegulation

Novo Nordisk has launched a once-daily Wegovy pill, marking the first oral GLP-1 medication approved for weight loss in the U.S. According to reports, this development provides an alternative to injectable treatments, which have seen significant demand. The Wegovy pill aims to broaden access to GLP-1 weight-loss drugs, offering a new option for individuals seeking treatment.

Read full story at Decrypt
Share:
📱

Never miss a Web3 update

Join our Telegram channel to receive news in real-time, straight to your phone.

Join Channel

Related News

Inside the Growing ‘Digisexual’ Subculture of People in Relationships With AI

Decrypt •1h ago

Kalshi, Polymarket eye $20B valuations in potential fundraising: WSJ

Cointelegraph•2h ago

USDC Surpasses Tether as Stablecoin Volume Reaches Record $1.8 Trillion

Cointelegraph•4h ago

Why Bitcoin keeps snapping back to $70k — and the $13B options “magnet” behind it

CryptoSlate•4h ago
← Back to News Feed